Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Short-term Investments (2020 - 2026)

NeuroPace has reported Short-term Investments over the past 7 years, most recently at $39.2 million for Q1 2026.

  • For Q1 2026, Short-term Investments changed 0.1% year-over-year to $39.2 million; the TTM value through Mar 2026 reached $39.2 million, changed 0.1%, while the annual FY2025 figure was $39.4 million, 0.1% changed from the prior year.
  • Short-term Investments for Q1 2026 was $39.2 million at NeuroPace, roughly flat from $39.4 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $95.7 million in Q1 2022 and troughed at $39.2 million in Q1 2026.
  • A 5-year average of $53.8 million and a median of $45.9 million in 2024 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: skyrocketed 473.35% in 2022 and later tumbled 36.36% in 2023.
  • Year by year, Short-term Investments stood at $70.8 million in 2022, then plummeted by 31.65% to $48.4 million in 2023, then decreased by 18.74% to $39.3 million in 2024, then increased by 0.1% to $39.4 million in 2025, then dropped by 0.42% to $39.2 million in 2026.
  • Business Quant data shows Short-term Investments for NPCE at $39.2 million in Q1 2026, $39.4 million in Q4 2025, and $39.4 million in Q3 2025.